Benjamin Halladay - Dec 9, 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role: Chief Financial Officer
Signature: /s/ Benjamin Looker, by power of attorney
Stock symbol: ESPR
Transactions as of: Dec 9, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/12/2022, 03:07 PM
Previous filing: Nov 16, 2022
Next filing: Mar 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ESPR	Common Stock	Award	$0	+44K	+222.55%	$0.00	63.8K	Dec 9, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ESPR	Stock Option (right to buy)	Award	$0	+66K		$0.00	66K	Dec 9, 2022	Common Stock	66K	$5.09	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Such award will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of December 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.
F2	Such options will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of December 15, 2022 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service.